Cypress Capital Management (Delaware)’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
Other funds holding ZBH
Cypress Capital Management (Delaware)'s ZBH Position: Q4 2022 in Review
Cypress Capital Management (Delaware) sold out of Zimmer Biomet (ZBH) in Q4 2022, closing a stake of 64,103 shares — an estimated $6.7M sold.
Cypress Capital Management (Delaware) first reported a position in ZBH in Q1 2018 and held it in 19 quarters. The position peaked at $13.1M in Q4 2020. 977 funds tracked by Wall St. Rank hold ZBH as of Q4 2022.
- Cypress Capital Management (Delaware) reported no remaining Zimmer Biomet position as of Q4 2022 after selling out during the quarter.
- Cypress Capital Management (Delaware) sold 64,103 Zimmer Biomet shares in Q4 2022, an estimated $6.7M.
- Cypress Capital Management (Delaware) first reported a position in Zimmer Biomet in Q1 2018 and held it in 19 quarters.
- Cypress Capital Management (Delaware)'s Zimmer Biomet position peaked at $13.1M in Q4 2020.
- 977 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2022.
Based on Cypress Capital Management (Delaware)'s 13F filing for Q4 2022.